from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0683/rpsG

LFCtreatmentdescriptionclass of inhibitor

0.774

Amikacinug/mL Amikacintranslation

0.860

Cap5-10ug/mL Capreomycintranslation

0.935

Rox10-50 ug/mL Roxithromycintranslation

1.483

SM2-5 ug/mL Streptomycintranslation

1.911

Tet5-10 ug/mL Tetracyclinetranslation

-0.532

Rif0.2-5ug/mL Rifampicintranscription

-0.093

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.440

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.147

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.713

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.594

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.129

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.837

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.697

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.635

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.141

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.322

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.174

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.359

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.259

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.808

KCN5-20 ug/mL Potassium cyaniderespiration

-1.132

NaN30.2-2 mM Sodium aziderespiration

1.070

Nigericin50 uM Nigericinrespiration

-1.480

TRC10-150 ug/mL Triclosanrespiration

-1.474

TRZ10-25 ug/mL Thioridazinerespiration

1.544

Valinomycin0.5-10 uM Valinomycinrespiration

0.551

ZnSO42 mM ZnSO4respiration

0.042

menadione6-10 ug/mL Menadionerespiration

0.062

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.523

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.179

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.627

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.830

NRP_1Non-replicating persistence stage 1dosRassociated

0.617

Amp0.2mg/mL AmpicillincellWall

0.588

Cephalexin20-100 ug/mL CephalexincellWall

0.502

Cerulenin0.32-5 ug/mL CerulenincellWall

0.502

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.401

EMB10-20 ug/mL EthambutolcellWall

0.687

Eta12-40 ug/mL EthionamidecellWall

1.041

INH0.2-0.4 ug/mL IsoniazidcellWall

0.524

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.140

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.183

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.125

BZA0.12 mg/mL BenzamidearomaticAmides

0.062

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.105

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.505

H2O24 mM hydrogen peroxideDNAdamaging

0.397

Levo10 ug/mL LevofloxacinDNAdamaging

0.933

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.191

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.165

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.732

UVUV-irradiationDNAdamaging

-1.399

ARP41-4 ug/mL Antitubercular compound ARP4?

0.269

Antimycin12.5-50 ug/mL Antimycin A?

0.308

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.021

PA_110-50 ug/mL Antitubercular compound PA-1?

0.318

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.159

PA8240.2-2 ug/mL PA-824?

-0.709

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.325

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.707

Verapamil50 uM Verapamil?

0.191

mercaptoethanol2 mM 2-Mercaptoethanol?

0.062

methoxatin10-20 ug/mL Methoxatin?